Resolian Acquires China-Based Bioanalytical CRO Denali Medpharma

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Health
Other Science
Research
Pharmaceutical
Science
Biotechnology
Resolian

More Like This

Ardena Expands Bioanalytical Services in Europe

Denovo Biopharma Announces a Major Breakthrough in Treatment‑Resistant Depression with Precision Medicine

PR Newswire associated0

BioCina and NovaCina Merger Bolsters Global CDMO Industry

Olon Receives 2025 CMO Excellence in Green Chemistry Award

(Graphic: Business Wire)

Avania Bolsters MedTech CRO Value Chain Capabilities With Two Acquisitions in Highly Strategic Areas of Engineering Design & Product Development and Market Access

Avania, the leading, global medical technology contract research organization and advisory services partner, announces its acquisition of Anagram. (Graphic: Business Wire)

Avania Buys Spanish MedTech CRO Anagram to Enhance Its Core CRO Offering in a New European Geography

Blue Wolf Capital to Create New CDMO Platform

PR Newswire associated0

Nordic Bioscience to make its precision medicine biomarker PRO-C3 available in China for research use only (RUO) in the first quarter of 2024.